Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-11-23
1997-02-18
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548517, C07D40904, A61K 3140
Patent
active
056042558
ABSTRACT:
Compounds, compositions and methods of treatment are described to control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia. The treatment includes administration of an N-(1-thienylcycloalkyl)alkenylamine compound as an antagonist to inhibit excitotoxic actions at major neuronal excitatory amino acid receptor sites. Compounds of most interest are those of the formula ##STR1## wherein R.sup.1 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl and alkoxy; wherein each of R.sup.2 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl, oxo and alkoxy; wherein R.sup.5 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl and alkoxy; and wherein the broken line within the N-containing ring represents a double bond between any two adjacent carbon atoms
REFERENCES:
patent: 4598143 (1986-07-01), Rice et al.
patent: 5401755 (1995-03-01), Rice et al.
N. Rothman, et al., Annals of Neurology 19(2): 105-111 (1986).
O. Anis, et al, Br. J. Pharmacol. 79: 565-575 (1983).
P. Olney, et al., Neuroscience Letters, 68: 29-34 (1986).
Q. Berry, et al., Eur. J. Pharm. 96: 261-267 (1983).
R. Goldman, et al., FEBS Letters, 190: 333-336 (1985).
S. Quirion, Proc. Natl. Acad. Sci., USA, 78: 5881-5885 (1981).
T. Snell, et al., J. Pharmacol. Exp. Ther., 235(1): 50-57 (1985).
U. Chem. Abstracts, 107(23): 211790y (Dec. 7, 1987).
V. Chem. Abstracts, Chemical Substance Index (Ph-Pz), 107:7975cs (Dec. 31, 1987).
W. Chem. Abstracts, Formula Index, C.sub.13 -C.sub.21, 107: 1663-F (Dec. 31, 1987).
Contreras Patricia C.
Gray Nancy M.
Jacobson Arthur E.
Mattson Mariena V.
O'Donohue Thomas L.
G. D. Searle & Co.
Rotman Alan L.
The United States of America as represented by the Department of
LandOfFree
N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1602835